Chemo drug vandetanib (caprelsa)
Ended Awarded Last action
- Contract number
- VA69D13J0630
- Awardee
-
Astrazeneca LIMITED Partnership UEI FBWCB39K5929
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $7,335
Award facts
- Contract value 100% obligated
- $7,334.96 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Hines, Proviso Township, IL, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract VA69D13J0630?
VA69D13J0630 was awarded to Astrazeneca LIMITED Partnership by Veterans Integrated Service Network 12 (Veterans Health Administration) on November 28, 2012.
How much is contract VA69D13J0630 worth?
The government has obligated $7,335 on VA69D13J0630.
Is contract VA69D13J0630 an order under another contract?
Yes. VA69D13J0630 is a delivery order under V797P2211D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA69D13J0630 competed?
The extent of competition for VA69D13J0630 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award